|Trial status||Trial open for recruitment|
Interventional with experimental drug
|Phase||Trial phase 2|
|Sponsor||Institut Jules Bordet|
|Inclusion criteria||No contraindication for immunotherapy|
The very latest radiotherapy equipment representing one more step on the road to perfecting our cancer treatment and the precision of our patient care.